mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |